"The editor-in-chief of a scientific journal with ties to China commissioned a commentary to refute the hypothesis that the novel coronavirus SARS-CoV-2 came from a lab, according to emails obtained by U.S. Right to Know.
The commentary reinforced a scientific narrative of certainty about natural origins of SARS-CoV-2, the virus that causes Covid-19, just a few weeks after the first reported outbreak in Wuhan, China.
The journal’s acceptance of the commentary for publication within 12 hours of its submission suggests a superficial peer-review process by a scientific publication to make a political point.
The commentary, written by U.S. virologists, was published around the same time as scientific reports and a statement from 27 scientists published in different journals that all asserted the new coronavirus had a natural origin.
The revelation that the editor-in-chief, Shan Lu of the University of Massachusetts Medical School, solicited the commentary for the journal Emerging Microbes & Infections (EMI) raises questions about whether there was coordination between political and scientific interests aligned with the Chinese government’s position on this highly controversial issue.
The journal’s editing is handled by Shanghai Shangyixun Cultural Communication Co. in China, in coordination with publisher Taylor & Francis, which is based in England. Several of the journal’s editors and board members are based in China, including some affiliated with the Chinese government.
EMI Board members Shibo Jiang at Fudan University School of Medicine and Yuelong Shu at Sun-Yat Sen University were among the group of Chinese scientists who sought to change the name of the new coronavirus to distance it from China; Dong Xiaoping is a governmental official at the Chinese Centers for Disease Control, who was the number two expert on the Chinese side of the February 2020 joint mission with the World Health Organization to elucidate the origins of SARS-CoV-2.
The February 2020 commentary is titled “No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2,” and was authored by virologists Shan-Lu Liu and Linda Saif of Ohio State University; Susan Weiss of the University of Pennsylvania; and Lishan Su, who at the time was affiliated with the University of North Carolina. The authors argued in their article against the possibility that SARS-CoV-2 originated from a lab leak of a bat coronavirus named RaTG13 that was housed within China’s Wuhan Institute of Virology (WIV).
The WIV is the world’s foremost coronavirus research facility and is located just a few miles from the site of the first reported outbreak in Wuhan, China. The authors also dismissed concerns that genetic alterations to SARS-related viruses created by WIV scientists in collaboration with a University of North Carolina laboratory could have been the source for SARS-CoV-2.
To date, WIV scientists and Chinese governmental authorities have not given independent scientists access to the WIV’s database of bat coronaviruses.
Speedy acceptance
In one February 11, 2020 email, Liu invited Saif to be co-author on an “almost complete” draft of “a commentary on the possible origin of the 2019-nCoV or SARSCoV-2 in order to dispute some rumors.” Liu said in the email that he had written the commentary with Su at the invitation of the editor-in-chief of Emerging Microbes & Infections.
Saif agreed to join, stating: “I edited this version and added my name as I too feel strongly about denouncing this.”
Saif separately was a signatory to the statement published in The Lancet that emails show was orchestrated by EcoHealth Alliance’s Peter Daszak. EcoHealth Alliance is a non-profit group that has received millions of dollars of U.S. taxpayer funding to genetically manipulate viruses, including with scientists at the Wuhan Institute of Virology.
On February 12, 2020, Liu also invited Professor Weiss to also be a co-author, and she immediately agreed.
Liu submitted the manuscript on the evening of February 12, and within 12 hours, the journal’s Shanghai-based editorial office accepted the paper, with one peer-reviewer noting: “This is a timely commentary. It is perfectly written… I suggest to publish it right away.”
In February 2020, EMI published two more commentaries, all of which were favorable to the Chinese government’s position on the origins of SARS-CoV-2:
- a Feb 4 commentary titled “HIV-1 did not contribute to the 2019-nCoV genome” by U.S.-based Chinese scientists with affiliations to Chinese universities; and
- a Feb 28 commentary titled “Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination,” by Shanghai-based scientists belonging to the Chinese Academy of Sciences.
Origins controversy continues
The experts who authored the EMI commentary did not consider that WIV houses unpublished SARS-related bat coronaviruses, which could have served as a template for the lab origin of SARS-CoV-2, according to some scientists. To date, debate on the matter of the virus’s origins remains open, and there are growing calls to investigate natural as well as lab-origin scenarios.
Stanford Professor David Relman wrote in a PNAS article that arguments against deliberate engineering scenarios “fail to acknowledge the possibility that two or more as yet undisclosed ancestors (i.e., more proximal ancestors than RaTG13 and RmYN02) had already been discovered and were being studied in a laboratory—for example, one with the SARS-CoV-2 backbone and spike protein receptor-binding domain, and the other with the SARS-CoV-2 polybasic furin cleavage site. It would have been a logical next step to wonder about the properties of a recombinant virus and then create it in the laboratory.”
For more information
Ohio State University Professor Linda Saif’s emails, which U.S. Right to Know obtained through a public records request, can be found here: Saif emails batch #1: Ohio State University (303 pages)
U.S. Right to Know is posting documents from our public records requests for our biohazards investigation. See: FOI documents on origins of SARS-CoV-2, hazards of gain-of-function research and biosafety labs.
Background page on U.S. Right to Know’s investigation into the origins of SARS-CoV-2.
Biohazards, Biohazards Blog Covid-19, laboratory biosafety, origins of coronavirus, SARS-CoV-2 origins controversy" https://usrtk.org/biohazards/chinese-linked-journal-sought-to-rebut-covid-19-lab-origin-theory/